Aigen Investment Management, LP Eagle Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $625,633 - $769,894	-14,996 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $555,151 - $768,994	14,996 New	14,996 $637,000
Q1 2020 May 08, 2020	SELL	$34.37 - $60.07 $3,127 - $5,466	-91 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$54.32 - $64.31 $4,943 - $5,852	91 New	91 $5,000

8.59M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $12.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.